Absence epilepsy is a nonconvulsive form of idiopathic generalized epilepsy that occurs most often in children and adolescents. It is characterized by 3-4 Hz spike-wave discharges (SWDs) in the electroencephalogram, which is manifest as transient loss of consciousness. Absence seizures are generally not associated with structural or metabolic abnormalities. Although a genetic etiology is presumed to underlie most cases of absence epilepsy, only a small number of causal single-gene mutations have been identified, and most cases likely result from complex genetic interactions. The single mutations that have been identified are in genes encoding voltage-gated calcium channels, GABA A receptors, and chloride channels (1).
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In Basic Science
Absence epilepsy is a nonconvulsive form of idiopathic generalized epilepsy that occurs most often in children and adolescents. It is characterized by 3-4 Hz spike-wave discharges (SWDs) in the electroencephalogram, which is manifest as transient loss of consciousness. Absence seizures are generally not associated with structural or metabolic abnormalities. Although a genetic etiology is presumed to underlie most cases of absence epilepsy, only a small number of causal single-gene mutations have been identified, and most cases likely result from complex genetic interactions. The single mutations that have been identified are in genes encoding voltage-gated calcium channels, GABA A receptors, and chloride channels (1).
Papale et al. (2) previously demonstrated that several alleles of the mouse Scn8a voltage-gated sodium channel gene, including Na v 1.6 V929F , result in absence epilepsy. The V929F mutation is in the pore region of domain 2 of the Na v 1.6 sodium channel. They observed a very strong strain-dependent effect, with a much higher incidence of SWDs on the C3HeB/FeJ (C3H) genetic background compared with C57BL/6J (B6J), supporting the hypothesis that complex genetic interactions underlie absence epilepsy.
In the current study, Oliva et al. (3) characterized the biophysical effects of the Scn8a V929F mutation and investigated the mechanism underlying the higher frequency of SWDs in the C3H genetic background. To determine how the mutation alters neuronal firing, they performed electrophysiologic analysis on Na v 1.6 V929F channels expressed in ND7/23 neuroblastoma cells. The mutation was found to decrease sodium channel function by shifting the voltage-dependence of activation in the positive direction and the voltage-dependence of inactivation in the negative direction. These studies had to be carried out using a neuronal cell line because the Na v 1.6 channel did not express at high enough levels for analysis in non-neuronal HEK293T cells. Because ND7/23 cells express endogenous sodium channels, the authors used a tetrodotoxin-resistant version of the mutant channel and blocked the endogenous tetrodotoxin-sensitive channels with tetrodotoxin.
The authors used two approaches to investigate the contribution of genetic background to SWD frequency: testing the role of a candidate gene and performing a genome scan to map modifier loci. The candidate gene was the Scn2a sodium channel gene encoding Na v 1.2, which was selected because the C3H Oliva In excitatory neurons, SCN2A (Na v 1.2) and SCN8A (Na v 1.6) sodium channels are enriched at the axon initial segment. Na v 1.6 is implicated in several mouse models of absence epilepsy, including a missense mutation identified in a chemical mutagenesis screen (Scn8a V929F ). Here, we confirmed the prior suggestion that Scn8a V929F exhibits a striking genetic background-dependent difference in phenotypic severity, observing that spike-wave discharge (SWD) incidence and severity are significantly diminished when Scn8a V929F is fully placed onto the C57BL/6J strain compared with C3H. Examination of sequence differences in Na v subunits between these two inbred strains suggested Na v 1.2 V752F as a potential source of this modifier effect. Recognising that the spatial co-localisation of the Na v channels at the axon initial segment (AIS) provides a plausible mechanism for functional interaction, we tested this idea by undertaking biophysical characterisation of the variant Na v channels and by computer modelling. Na v 1.2 V752F functional analysis revealed an overall gain-of-function and for Na v 1.6 V929F revealed an overall loss-of-function. A biophysically realistic computer model was used to test the idea that interaction between these variant channels at the AIS contributes to the strain background effect. Surprisingly this modelling showed that neuronal excitability is dominated by the properties of Na v 1.2 V752F due to "functional silencing" of Na v 1.6 V929F suggesting that these variants do not directly interact. Consequent genetic mapping of the major strain modifier to Chr 7, and not Chr 2 where Scn2a maps, supported this biophysical prediction. While a Na v 1.6 V929F loss of function clearly underlies absence seizures in this mouse model, the strain background effect is apparently not due to an otherwise tempting Scn2a variant, highlighting the value of combining physiology and genetics to inform and direct each other when interrogating genetic complex traits such as absence epilepsy.
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Complex Genetic Interactions in a Mouse Model of Absence Epilepsy
strain harbors a variant (V752F) in this gene. The hypothesis that the Na v 1.2 and Na v 1.6 sodium channels interact is quite plausible because these two channels are both present at the axon initial segment. To test this hypothesis, the authors first showed that the Na v 1.2 V752F mutation increased sodium current activity by increasing current density and shifting activation to more negative potentials, which is the opposite effect compared with V929F in Na v 1.6. To test for an interaction, the authors used a computational approach in which they modeled the properties of the two mutant channels separately and together in a single cortical layer 5 pyramidal neuron. This class of neuron is a reasonable model because it is known to have inputs and outputs to the thalamus, the site of SWDs in absence epilepsy. The surprising result was that the V752F mutation was dominant, resulting in more action potential firing. These results suggest that the two mutant channels do not interact even though the two channels are localized in the same region of the neuron (the axon initial segment). The effect of the Scn8a mutation is masked in the presence of the Scn2a mutation.
The authors then used a genetic strategy to map the location of modifier loci, back-crossing Scn8a V929F mutant mice on the B6J background to wild-type C3H mice. The distribution of SWD incidence and duration in the resulting offspring suggested a complex inheritance pattern indicative of multiple trait loci contributing to the modifier effect. By performing a genome scan using 184 single nucleotide polymorphism markers, they identified a region on chromosome 7 that significantly affects SWD length. The region was confirmed by selectively breeding this region from C3H mice onto the B6J background. The region that was localized is quite large and includes 26 protein-coding and 43 non-coding RNA or unclassified genes. Although the authors suggested some candidate genes in this region, it will require further analysis to identify the modifier gene.
This study makes three salient points. First, it confirms the role of mutations in the Scn8a sodium channel gene in causing absence seizures, while at the same time providing data suggesting that the Scn2a sodium channel gene is not involved in absence epilepsy. Second, it reaffirms that absence epilepsy is a complex genetic trait, even in cases caused by single gene mutations. Finally, this study demonstrates the power of computer modeling as a means of testing for functional interactions between mutations. The two sodium channels (Na v 1.2 and Na v 1.6) are in an ideal position for functional interaction because of their close proximity in the axon initial segment, but the modeling strongly indicates that this is not the case.
Several important questions remain. First, do mutations in the human SCN8A gene cause or modify absence epilepsy? Decreased Na v 1.6 function has been shown to provide protection from convulsive seizures in mice (4, 5) , and mutations in the human SCN8A gene have been identified as causing convulsive seizures (6-9), but no human mutations have yet been identified in patients with absence epilepsy. Second, how does reduced activity of the Na v 1.6 sodium channel lead to SWDs and absence epilepsy? The electrophysiologic assays and computer modeling demonstrate functional effects on neuronal activity, but it is unclear how those alterations lead to SWDs. Third, do specific types of neurons (for example, excitatory vs inhibitory) play a critical role in SWD generation due to Scn8a mutations? Finally, what is the modifier gene on chromosome 7, and what other loci might influence SWD presentation? It is likely that most cases of absence epilepsy result from mutations in multiple genes, with each one contributing a small amount toward the phenotype. If that is the case, then the identification of modifier genes might shed light on the factors that influence susceptibility to absence seizures.
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